+关注
layais
暂无个人介绍
IP属地：河北
847
关注
3
粉丝
1
主题
0
勋章
主贴
热门
layais
2022-01-15
mark
抱歉，原内容已删除
layais
2021-12-15
mark
康耐特光学一手中签率50.38%，认购2手稳中一手
去老虎APP查看更多动态
{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3549254900032412","uuid":"3549254900032412","gmtCreate":1586160877253,"gmtModify":1670551992544,"name":"layais","pinyin":"layais","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/cece62534a180c5d52e5ce98e540008f","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":3,"headSize":847,"tweetSize":2,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":1,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":1,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-3","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"偶像虎友","description":"加入老虎社区1500天","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.05.16","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"228c86a078844d74991fff2b7ab2428d-2","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资总监虎","description":"证券账户累计交易金额达到30万美元","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"80.96%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.05.10","exceedPercentage":"80.35%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"河北","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":697981113,"gmtCreate":1642212416788,"gmtModify":1642212416788,"author":{"id":"3549254900032412","authorId":"3549254900032412","name":"layais","avatar":"https://static.tigerbbs.com/cece62534a180c5d52e5ce98e540008f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3549254900032412","authorIdStr":"3549254900032412"},"themes":[],"htmlText":"mark","listText":"mark","text":"mark","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/697981113","repostId":"1126777532","repostType":2,"isVote":1,"tweetType":1,"viewCount":3347,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607656817,"gmtCreate":1639535903706,"gmtModify":1639535903706,"author":{"id":"3549254900032412","authorId":"3549254900032412","name":"layais","avatar":"https://static.tigerbbs.com/cece62534a180c5d52e5ce98e540008f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3549254900032412","authorIdStr":"3549254900032412"},"themes":[],"htmlText":"mark","listText":"mark","text":"mark","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/607656817","repostId":"1197075228","repostType":4,"repost":{"id":"1197075228","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639531128,"share":"https://www.laohu8.com/m/news/1197075228?lang=&edition=full","pubTime":"2021-12-15 09:18","market":"hk","language":"zh","title":"康耐特光学一手中签率50.38%，认购2手稳中一手","url":"https://stock-news.laohu8.com/highlight/detail?id=1197075228","media":"老虎资讯综合","summary":"康耐特光学主要从事标准化及定制镜片的生产及销售。","content":"<p>12月15日，<a href=\"https://laohu8.com/S/02276\">康耐特光学</a>发布公告，公司全球发售约1.216亿股股份，其中香港发售股份1216万股，国际发售股份约1.09亿股，另有15%超额配股权；发售价已厘定为每股H股4.46港元，每手买卖单位500股；国泰君安国际为独家保荐人；预期股份将于2021年12月16日于联交所主板挂牌上市。</p>\n<p><b>老虎资讯整理相关数据如下：</b></p>\n<p><img src=\"https://static.tigerbbs.com/3e9c56794702684c18c52114972d5a3f\" tg-width=\"1059\" tg-height=\"824\" referrerpolicy=\"no-referrer\"><b>分配结果</b></p>\n<p>甲组每手500股，一手中签率50.38%，申购2手稳中一手。</p>\n<p>乙组头为1800手（900,000股），获配1800手（900,000股）。<img src=\"https://static.tigerbbs.com/e6a4b94fe5f572d6454ad77d743ca31f\" tg-width=\"436\" tg-height=\"500\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/7a4c77d0f8e444166488b514fbd71445\" tg-width=\"421\" tg-height=\"287\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/1f026c13af6b6861625617f2136488b9\" tg-width=\"425\" tg-height=\"157\" referrerpolicy=\"no-referrer\"></p>\n<p>根据每股H股发售价4.46港元，公司自全球发售收取的所得款项净额估计约为4.74亿港元(假设超额配股权并无获行使)。公司拟将所得款项净额约46.4%将用于提高上海生产基地及江苏生产基地的产能;约19.9%将用于加强公司研发实力;约10.3%将用于加大公司的销售及营销力度;约10.0%将用作营运资金及一般企业用途;约8.1%将用于提升生产效率及工艺的技术;约5.3%将用于偿还银行借款未偿还款项，该等借款主要用于拨付营运资金以支持业务运作。</p>\n<p><b>公司简介</b></p>\n<p>康耐特光学为一家树脂眼镜镜片制造商，于往绩记录期在超过80个国家进行销售，包括但不限于中国、美国、日本、印度、澳洲、泰国、德国及巴西。</p>\n<p>康耐特光学主要从事标准化及定制镜片的生产及销售，两者均为半成品，需作进一步加工。</p>\n<p>定制镜片及标准化镜片（除镜片毛坯外）需要简单的进一步加工，例如切割镜片并将其组装到镜架上以制成眼镜。</p>\n<p>康耐特光学可以协助客户切割镜片并将其组装到镜架上，作为康耐特光学为彼等提供的增值服务。</p>\n<p>康耐特光学主要通过ODM（原设计制造）业务模式运营。</p>\n<p>招股书显示，康耐特光学在2018年、2019年、2020年营收分别为8.54亿元、10.59亿、10.93亿；净利润分别为7846万元、1.12亿元、 1.28亿元。</p>\n<p><img src=\"https://static.tigerbbs.com/f1e8238f81e3b2f998d92fd7e7026f40\" tg-width=\"1080\" tg-height=\"332\" referrerpolicy=\"no-referrer\"></p>\n<p>康耐特光学在2021年前5个月营收为5.38亿元，上年同期的营收为3.64亿元；净利润为6458万元，上年同期的净利润为3250万元。</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>康耐特光学一手中签率50.38%，认购2手稳中一手</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n康耐特光学一手中签率50.38%，认购2手稳中一手\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2021-12-15 09:18</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>12月15日，<a href=\"https://laohu8.com/S/02276\">康耐特光学</a>发布公告，公司全球发售约1.216亿股股份，其中香港发售股份1216万股，国际发售股份约1.09亿股，另有15%超额配股权；发售价已厘定为每股H股4.46港元，每手买卖单位500股；国泰君安国际为独家保荐人；预期股份将于2021年12月16日于联交所主板挂牌上市。</p>\n<p><b>老虎资讯整理相关数据如下：</b></p>\n<p><img src=\"https://static.tigerbbs.com/3e9c56794702684c18c52114972d5a3f\" tg-width=\"1059\" tg-height=\"824\" referrerpolicy=\"no-referrer\"><b>分配结果</b></p>\n<p>甲组每手500股，一手中签率50.38%，申购2手稳中一手。</p>\n<p>乙组头为1800手（900,000股），获配1800手（900,000股）。<img src=\"https://static.tigerbbs.com/e6a4b94fe5f572d6454ad77d743ca31f\" tg-width=\"436\" tg-height=\"500\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/7a4c77d0f8e444166488b514fbd71445\" tg-width=\"421\" tg-height=\"287\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/1f026c13af6b6861625617f2136488b9\" tg-width=\"425\" tg-height=\"157\" referrerpolicy=\"no-referrer\"></p>\n<p>根据每股H股发售价4.46港元，公司自全球发售收取的所得款项净额估计约为4.74亿港元(假设超额配股权并无获行使)。公司拟将所得款项净额约46.4%将用于提高上海生产基地及江苏生产基地的产能;约19.9%将用于加强公司研发实力;约10.3%将用于加大公司的销售及营销力度;约10.0%将用作营运资金及一般企业用途;约8.1%将用于提升生产效率及工艺的技术;约5.3%将用于偿还银行借款未偿还款项，该等借款主要用于拨付营运资金以支持业务运作。</p>\n<p><b>公司简介</b></p>\n<p>康耐特光学为一家树脂眼镜镜片制造商，于往绩记录期在超过80个国家进行销售，包括但不限于中国、美国、日本、印度、澳洲、泰国、德国及巴西。</p>\n<p>康耐特光学主要从事标准化及定制镜片的生产及销售，两者均为半成品，需作进一步加工。</p>\n<p>定制镜片及标准化镜片（除镜片毛坯外）需要简单的进一步加工，例如切割镜片并将其组装到镜架上以制成眼镜。</p>\n<p>康耐特光学可以协助客户切割镜片并将其组装到镜架上，作为康耐特光学为彼等提供的增值服务。</p>\n<p>康耐特光学主要通过ODM（原设计制造）业务模式运营。</p>\n<p>招股书显示，康耐特光学在2018年、2019年、2020年营收分别为8.54亿元、10.59亿、10.93亿；净利润分别为7846万元、1.12亿元、 1.28亿元。</p>\n<p><img src=\"https://static.tigerbbs.com/f1e8238f81e3b2f998d92fd7e7026f40\" tg-width=\"1080\" tg-height=\"332\" referrerpolicy=\"no-referrer\"></p>\n<p>康耐特光学在2021年前5个月营收为5.38亿元，上年同期的营收为3.64亿元；净利润为6458万元，上年同期的净利润为3250万元。</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/809f871ae293a812e32417368b3bad7e","relate_stocks":{},"is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1197075228","content_text":"12月15日，康耐特光学发布公告，公司全球发售约1.216亿股股份，其中香港发售股份1216万股，国际发售股份约1.09亿股，另有15%超额配股权；发售价已厘定为每股H股4.46港元，每手买卖单位500股；国泰君安国际为独家保荐人；预期股份将于2021年12月16日于联交所主板挂牌上市。\n老虎资讯整理相关数据如下：\n分配结果\n甲组每手500股，一手中签率50.38%，申购2手稳中一手。\n乙组头为1800手（900,000股），获配1800手（900,000股）。\n根据每股H股发售价4.46港元，公司自全球发售收取的所得款项净额估计约为4.74亿港元(假设超额配股权并无获行使)。公司拟将所得款项净额约46.4%将用于提高上海生产基地及江苏生产基地的产能;约19.9%将用于加强公司研发实力;约10.3%将用于加大公司的销售及营销力度;约10.0%将用作营运资金及一般企业用途;约8.1%将用于提升生产效率及工艺的技术;约5.3%将用于偿还银行借款未偿还款项，该等借款主要用于拨付营运资金以支持业务运作。\n公司简介\n康耐特光学为一家树脂眼镜镜片制造商，于往绩记录期在超过80个国家进行销售，包括但不限于中国、美国、日本、印度、澳洲、泰国、德国及巴西。\n康耐特光学主要从事标准化及定制镜片的生产及销售，两者均为半成品，需作进一步加工。\n定制镜片及标准化镜片（除镜片毛坯外）需要简单的进一步加工，例如切割镜片并将其组装到镜架上以制成眼镜。\n康耐特光学可以协助客户切割镜片并将其组装到镜架上，作为康耐特光学为彼等提供的增值服务。\n康耐特光学主要通过ODM（原设计制造）业务模式运营。\n招股书显示，康耐特光学在2018年、2019年、2020年营收分别为8.54亿元、10.59亿、10.93亿；净利润分别为7846万元、1.12亿元、 1.28亿元。\n\n康耐特光学在2021年前5个月营收为5.38亿元，上年同期的营收为3.64亿元；净利润为6458万元，上年同期的净利润为3250万元。","news_type":1,"symbols_score_info":{"02276":0.9}},"isVote":1,"tweetType":1,"viewCount":3241,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":697981113,"gmtCreate":1642212416788,"gmtModify":1642212416788,"author":{"id":"3549254900032412","authorId":"3549254900032412","name":"layais","avatar":"https://static.tigerbbs.com/cece62534a180c5d52e5ce98e540008f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3549254900032412","authorIdStr":"3549254900032412"},"themes":[],"htmlText":"mark","listText":"mark","text":"mark","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/697981113","repostId":"1126777532","repostType":2,"isVote":1,"tweetType":1,"viewCount":3347,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607656817,"gmtCreate":1639535903706,"gmtModify":1639535903706,"author":{"id":"3549254900032412","authorId":"3549254900032412","name":"layais","avatar":"https://static.tigerbbs.com/cece62534a180c5d52e5ce98e540008f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3549254900032412","authorIdStr":"3549254900032412"},"themes":[],"htmlText":"mark","listText":"mark","text":"mark","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/607656817","repostId":"1197075228","repostType":4,"repost":{"id":"1197075228","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639531128,"share":"https://www.laohu8.com/m/news/1197075228?lang=&edition=full","pubTime":"2021-12-15 09:18","market":"hk","language":"zh","title":"康耐特光学一手中签率50.38%，认购2手稳中一手","url":"https://stock-news.laohu8.com/highlight/detail?id=1197075228","media":"老虎资讯综合","summary":"康耐特光学主要从事标准化及定制镜片的生产及销售。","content":"<p>12月15日，<a href=\"https://laohu8.com/S/02276\">康耐特光学</a>发布公告，公司全球发售约1.216亿股股份，其中香港发售股份1216万股，国际发售股份约1.09亿股，另有15%超额配股权；发售价已厘定为每股H股4.46港元，每手买卖单位500股；国泰君安国际为独家保荐人；预期股份将于2021年12月16日于联交所主板挂牌上市。</p>\n<p><b>老虎资讯整理相关数据如下：</b></p>\n<p><img src=\"https://static.tigerbbs.com/3e9c56794702684c18c52114972d5a3f\" tg-width=\"1059\" tg-height=\"824\" referrerpolicy=\"no-referrer\"><b>分配结果</b></p>\n<p>甲组每手500股，一手中签率50.38%，申购2手稳中一手。</p>\n<p>乙组头为1800手（900,000股），获配1800手（900,000股）。<img src=\"https://static.tigerbbs.com/e6a4b94fe5f572d6454ad77d743ca31f\" tg-width=\"436\" tg-height=\"500\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/7a4c77d0f8e444166488b514fbd71445\" tg-width=\"421\" tg-height=\"287\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/1f026c13af6b6861625617f2136488b9\" tg-width=\"425\" tg-height=\"157\" referrerpolicy=\"no-referrer\"></p>\n<p>根据每股H股发售价4.46港元，公司自全球发售收取的所得款项净额估计约为4.74亿港元(假设超额配股权并无获行使)。公司拟将所得款项净额约46.4%将用于提高上海生产基地及江苏生产基地的产能;约19.9%将用于加强公司研发实力;约10.3%将用于加大公司的销售及营销力度;约10.0%将用作营运资金及一般企业用途;约8.1%将用于提升生产效率及工艺的技术;约5.3%将用于偿还银行借款未偿还款项，该等借款主要用于拨付营运资金以支持业务运作。</p>\n<p><b>公司简介</b></p>\n<p>康耐特光学为一家树脂眼镜镜片制造商，于往绩记录期在超过80个国家进行销售，包括但不限于中国、美国、日本、印度、澳洲、泰国、德国及巴西。</p>\n<p>康耐特光学主要从事标准化及定制镜片的生产及销售，两者均为半成品，需作进一步加工。</p>\n<p>定制镜片及标准化镜片（除镜片毛坯外）需要简单的进一步加工，例如切割镜片并将其组装到镜架上以制成眼镜。</p>\n<p>康耐特光学可以协助客户切割镜片并将其组装到镜架上，作为康耐特光学为彼等提供的增值服务。</p>\n<p>康耐特光学主要通过ODM（原设计制造）业务模式运营。</p>\n<p>招股书显示，康耐特光学在2018年、2019年、2020年营收分别为8.54亿元、10.59亿、10.93亿；净利润分别为7846万元、1.12亿元、 1.28亿元。</p>\n<p><img src=\"https://static.tigerbbs.com/f1e8238f81e3b2f998d92fd7e7026f40\" tg-width=\"1080\" tg-height=\"332\" referrerpolicy=\"no-referrer\"></p>\n<p>康耐特光学在2021年前5个月营收为5.38亿元，上年同期的营收为3.64亿元；净利润为6458万元，上年同期的净利润为3250万元。</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>康耐特光学一手中签率50.38%，认购2手稳中一手</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n康耐特光学一手中签率50.38%，认购2手稳中一手\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2021-12-15 09:18</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>12月15日，<a href=\"https://laohu8.com/S/02276\">康耐特光学</a>发布公告，公司全球发售约1.216亿股股份，其中香港发售股份1216万股，国际发售股份约1.09亿股，另有15%超额配股权；发售价已厘定为每股H股4.46港元，每手买卖单位500股；国泰君安国际为独家保荐人；预期股份将于2021年12月16日于联交所主板挂牌上市。</p>\n<p><b>老虎资讯整理相关数据如下：</b></p>\n<p><img src=\"https://static.tigerbbs.com/3e9c56794702684c18c52114972d5a3f\" tg-width=\"1059\" tg-height=\"824\" referrerpolicy=\"no-referrer\"><b>分配结果</b></p>\n<p>甲组每手500股，一手中签率50.38%，申购2手稳中一手。</p>\n<p>乙组头为1800手（900,000股），获配1800手（900,000股）。<img src=\"https://static.tigerbbs.com/e6a4b94fe5f572d6454ad77d743ca31f\" tg-width=\"436\" tg-height=\"500\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/7a4c77d0f8e444166488b514fbd71445\" tg-width=\"421\" tg-height=\"287\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/1f026c13af6b6861625617f2136488b9\" tg-width=\"425\" tg-height=\"157\" referrerpolicy=\"no-referrer\"></p>\n<p>根据每股H股发售价4.46港元，公司自全球发售收取的所得款项净额估计约为4.74亿港元(假设超额配股权并无获行使)。公司拟将所得款项净额约46.4%将用于提高上海生产基地及江苏生产基地的产能;约19.9%将用于加强公司研发实力;约10.3%将用于加大公司的销售及营销力度;约10.0%将用作营运资金及一般企业用途;约8.1%将用于提升生产效率及工艺的技术;约5.3%将用于偿还银行借款未偿还款项，该等借款主要用于拨付营运资金以支持业务运作。</p>\n<p><b>公司简介</b></p>\n<p>康耐特光学为一家树脂眼镜镜片制造商，于往绩记录期在超过80个国家进行销售，包括但不限于中国、美国、日本、印度、澳洲、泰国、德国及巴西。</p>\n<p>康耐特光学主要从事标准化及定制镜片的生产及销售，两者均为半成品，需作进一步加工。</p>\n<p>定制镜片及标准化镜片（除镜片毛坯外）需要简单的进一步加工，例如切割镜片并将其组装到镜架上以制成眼镜。</p>\n<p>康耐特光学可以协助客户切割镜片并将其组装到镜架上，作为康耐特光学为彼等提供的增值服务。</p>\n<p>康耐特光学主要通过ODM（原设计制造）业务模式运营。</p>\n<p>招股书显示，康耐特光学在2018年、2019年、2020年营收分别为8.54亿元、10.59亿、10.93亿；净利润分别为7846万元、1.12亿元、 1.28亿元。</p>\n<p><img src=\"https://static.tigerbbs.com/f1e8238f81e3b2f998d92fd7e7026f40\" tg-width=\"1080\" tg-height=\"332\" referrerpolicy=\"no-referrer\"></p>\n<p>康耐特光学在2021年前5个月营收为5.38亿元，上年同期的营收为3.64亿元；净利润为6458万元，上年同期的净利润为3250万元。</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/809f871ae293a812e32417368b3bad7e","relate_stocks":{},"is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1197075228","content_text":"12月15日，康耐特光学发布公告，公司全球发售约1.216亿股股份，其中香港发售股份1216万股，国际发售股份约1.09亿股，另有15%超额配股权；发售价已厘定为每股H股4.46港元，每手买卖单位500股；国泰君安国际为独家保荐人；预期股份将于2021年12月16日于联交所主板挂牌上市。\n老虎资讯整理相关数据如下：\n分配结果\n甲组每手500股，一手中签率50.38%，申购2手稳中一手。\n乙组头为1800手（900,000股），获配1800手（900,000股）。\n根据每股H股发售价4.46港元，公司自全球发售收取的所得款项净额估计约为4.74亿港元(假设超额配股权并无获行使)。公司拟将所得款项净额约46.4%将用于提高上海生产基地及江苏生产基地的产能;约19.9%将用于加强公司研发实力;约10.3%将用于加大公司的销售及营销力度;约10.0%将用作营运资金及一般企业用途;约8.1%将用于提升生产效率及工艺的技术;约5.3%将用于偿还银行借款未偿还款项，该等借款主要用于拨付营运资金以支持业务运作。\n公司简介\n康耐特光学为一家树脂眼镜镜片制造商，于往绩记录期在超过80个国家进行销售，包括但不限于中国、美国、日本、印度、澳洲、泰国、德国及巴西。\n康耐特光学主要从事标准化及定制镜片的生产及销售，两者均为半成品，需作进一步加工。\n定制镜片及标准化镜片（除镜片毛坯外）需要简单的进一步加工，例如切割镜片并将其组装到镜架上以制成眼镜。\n康耐特光学可以协助客户切割镜片并将其组装到镜架上，作为康耐特光学为彼等提供的增值服务。\n康耐特光学主要通过ODM（原设计制造）业务模式运营。\n招股书显示，康耐特光学在2018年、2019年、2020年营收分别为8.54亿元、10.59亿、10.93亿；净利润分别为7846万元、1.12亿元、 1.28亿元。\n\n康耐特光学在2021年前5个月营收为5.38亿元，上年同期的营收为3.64亿元；净利润为6458万元，上年同期的净利润为3250万元。","news_type":1,"symbols_score_info":{"02276":0.9}},"isVote":1,"tweetType":1,"viewCount":3241,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}
